A spectrophotometric assay for histone deacetylase 8

Analytical Biochemistry

Volumn 372, Issue 1, 2008, Pages 82-88

  Fatkins, David G ^a   Zheng, Weiping ^a  

^a UNIVERSITY OF AKRON   (United States)

Author keywords

DTNB; HDAC8; Spectrophotometric assay

Indexed keywords

AMINO ACIDS; CATALYSIS; DIAGNOSIS; ENZYMES; LANTHANUM COMPOUNDS; SPECTROPHOTOMETRY;

DRUG DISCOVERY PROCESS; DTNB; ENZYME CATALYZED REACTION; HDAC8; PHYSIOLOGICAL CONDITION; SELECTIVE INHIBITORS; SPECTROPHOTOMETRIC ASSAYS; TUMOR SUPPRESSOR PROTEINS;

SPECTROPHOTOMETERS;

HISTONE DEACETYLASE 8; LYSINE DERIVATIVE; N ACETYL LYSINE; N THIOACETYL LYSINE; PEPTIDE; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SCREENING; SPECTROPHOTOMETRY;

EID: 36048952471     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.08.031     Document Type: Article

References (35)

1. Yang X.J. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res. 32 (2004) 959-976
2. Yang X.J., and Gregoire S. Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol. Cell. Biol. 25 (2005) 2873-2884
3. Glozak M.A., Sengupta N., Zhang X., and Seto E. Acetylation and deacetylation of non-histone proteins. Gene 363 (2005) 15-23
4. Pagans S., Pedal A., North B.J., Kaehlcke K., Marshall B.L., Dorr A., Hetzer-Egger C., Henklein P., Frye R., McBurney M.W., Hruby H., Jung M., Verdin E., and Ott M. SIRT1 Regulates HIV Transcription via Tat Deacetylation. PLoS Biol. 3 (2005) e41
5. Denu J.M. The Sir 2 family of protein deacetylases. Curr. Opin. Chem. Biol. 9 (2005) 431-440
6. North B.J., and Sinclair D.A. Sirtuins: a conserved key unlocking AceCS activity. Trends Biochem. Sci. 32 (2007) 1-4
7. Michan S., and Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem. J. 404 (2007) 1-13
8. Thiagalingam S., Cheng K.H., Lee H.J., Mineva N., Thiagalingam A., and Ponte J.F. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann. N. Y. Acad. Sci. 983 (2003) 84-100
9. Gregoretti I.V., Lee Y.M., and Goodson H.V. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J. Mol. Biol. 338 (2004) 17-31
10. Monneret C. Histone deacetylase inhibitors for epigenetic therapy of cancer. Anticancer Drugs 18 (2007) 363-370
11. Marks P.A. Discovery and development of SAHA as an anticancer agent. Oncogene 26 (2007) 1351-1356
12. ε-deacetylation. Bioorg. Med. Chem. Lett. 16 (2006) 3651-3656
13. Riddles P.W., Blakeley R.L., and Zerner B. Reassessment of Ellman's reagent. Methods Enzymol. 91 (1983) 49-60
14. Wellings D.A., and Atherton E. Standard Fmoc protocols. Methods Enzymol. 289 (1997) 44-67
15. Jamonnak N., Fatkins D.G., Wei L., and Zheng W. N(epsilon)-Methanesulfonyl-lysine as a non-hydrolyzable functional surrogate for N(epsilon)-acetyl-lysine. Org. Biomol. Chem. 5 (2007) 892-896
16. + -dependent deacetylation reactions. Biochemistry 40 (2001) 15456-15463
17. Smith J.S., Avalos J., Celic I., Muhammad S., Wolberger C., and Boeke J.D. SIR2 family of NAD(+)-dependent protein deacetylases. Methods Enzymol. 353 (2002) 282-300
18. Avalos J.L., Celic I., Muhammad S., Cosgrove M.S., Boeke J.D., and Wolberger C. Structure of a Sir2 enzyme bound to an acetylated p53 peptide. Mol. Cell 10 (2002) 523-535
19. Whitesides G.M., Lilburn J.E., and Szajewski R.P. Rates of thiol-disulfide interchange reactions between mono- and dithiols and Ellman's reagent. J. Org. Chem. 42 (1977) 332-338
20. Campbell P., and Nashed N.T. Carboxypeptidase A catalyzed hydrolysis of thiopeptide and thioester analogs of specific substrates. An effect on kcat for peptide, but not ester, substrates. J. Am. Chem. Soc. 104 (1982) 5221-5226
21. Hildmann C., Wegener D., Riester D., Hempel R., Schober A., Merana J., Giurato L., Guccione S., Nielsen T.K., Ficner R., and Schwienhorst A. Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases. J. Biotechnol. 124 (2006) 258-270
22. Riester D., Wegener D., Hildmann C., and Schwienhorst A. Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates. Biochem. Biophys. Res. Commun. 324 (2004) 1116-1123
23. BIOMOL International, L.P. (Plymouth Meeting, PA, USA), HDAC8 Fluorimetric Drug Discovery Kit, http://www.biomol.com/Online_Catalog/Online_Catalog/Products/Product_Detail/38/?categoryId=214&productId=2855&mid=75.
24. th Ed.) P.20.
25. Finnin M.S., Donigian J.R., Cohen A., Richon V.M., Rifkind R.A., Marks P.A., Breslow R., and Pavletich N.P. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401 (1999) 188-193
26. Somoza J.R., Skene R.J., Katz B.A., Mol C., Ho J.D., Jennings A.J., Luong C., Arvai A., Buggy J.J., Chi E., Tang J., Sang B.C., Verner E., Wynands R., Leahy E.M., Dougan D.R., Snell G., Navre M., Knuth M.W., Swanson R.V., McRee D.E., and Tari L.W. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 12 (2004) 1325-1334
27. Vannini A., Volpari C., Filocamo G., Casavola E.C., Brunetti M., Renzoni D., Chakravarty P., Paolini C., De Francesco R., Gallinari P., Steinkuhler C., and Di Marco S. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. Proc. Natl. Acad. Sci. USA 101 (2004) 15064-15069
28. Nielsen T.K., Hildmann C., Dickmanns A., Schwienhorst A., and Ficner R. Crystal structure of a bacterial class 2 histone deacetylase homologue. J. Mol. Biol. 354 (2005) 107-120
29. Hu E., Dul E., Sung C.M., Chen Z., Kirkpatrick R., Zhang G.F., Johanson K., Liu R., Lago A., Hofmann G., Macarron R., de los Frailes M., Perez P., Krawiec J., Winkler J., and Jaye M. Identification of novel isoform-selective inhibitors within class I histone deacetylases. J. Pharmacol. Exp. Ther. 307 (2003) 720-728
30. Krennhrubec K., Marshall B.L., Hedglin M., Verdin E., and Ulrich S.M. Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors. Bioorg. Med. Chem. Lett. 17 (2007) 2874-2878
31. Wang D.F., Helquist P., Wiech N.L., and Wiest O. Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases. J. Med. Chem. 48 (2005) 6936-6947
32. Heltweg B., Trapp J., and Jung M. In vitro assays for the determination of histone deacetylase activity. Methods 36 (2005) 332-337
33. Cayman Chemical (Ann Arbor, MI, USA), HDAC Activity/Inhibitor Screening Assay Kit, http://www.caymanchem.com/app/template/Product.vm/catalog/789701/a/z.
34. BPS Bioscience Inc. (San Diego, CA, USA), Fluorogenic HDAC assay kit, http://www.bpsbioscience.com/hdac.php.
35. Riester D., Hildmann C., Schwienhorst A., and Meyer-Almes F.J. Histone deacetylase inhibitor assay based on fluorescence resonance energy transfer. Anal. Biochem. 362 (2007) 136-141